{
  "patient_info": {
    "name": "Franco Jessica",
    "test_date": "10/03/2025",
    "gender": "Female",
    "age": 43,
    "weight_kg": 65,
    "height_cm": 165,
    "test_source": "PNOE"
  },
  "core_scores": {
    "metabolic_rate": 85,
    "fat_burning": 51,
    "lung_util": 93,
    "hrv": 82,
    "symp_parasym": 57,
    "ventilation_eff": 77,
    "breathing_coord": 69
  },
  "caloric_data": {
    "rmr": 500,
    "fat_percent": 35,
    "cho_percent": 65,
    "burn_rest": 2022,
    "burn_workout": 2280,
    "eat_rest": 2222,
    "eat_workout": 2580
  },
  "metabolic_data": {
    "rmr": 500,
    "rer": 200.0
  },
  "heart_rate_data": {},
  "all_text": [
    "PNOE Ergometry results\nSubject \uf044 Measurement\nName Franco Jessica Status \u2713 Closed\nGender Female (43) Date 10/03/2025 13:38:57\nWeight 65 kg Duration 11' (67 breaths)\nHeight 165 cm Protocol \uf0c1Grow - RMR (/Protocol/Edit?id=819c33a7-6215-4d47-aa22-aed301484062)\nExercise Frequency 3 times a week Device PNOE 2516-338 / Ambient\nExercise Goal Strength Development Granular HR 642\nReport Type RMR\nRMR\n500\nVO2 (ml/min)\n400\nVCO2 (ml/min)\n300\n200\n100\n0\n50 100 150 200 250 300 350 400 450 500 550 600\nTime (sec)\n)nim/lm(\n2OCV\n&\n2OV\n100\n[02] Heart Rate\n95\n90\n85\n80\n50 100 150 200 250 300 350 400 450 500 550 600\nTime (sec)\n)mpb(\nRH\n1.6\n1.5\n1.4\n1.3\n1.2\n1.1\n1.0\n0.9\n0.8\n0.7\n0.6\n0.5\n50 100 150 200 250 300 350 400 450 500 550 600\nTime (sec)\n)-(\nRER",
    "70 VE/VO2\nVE/VCO2\n60\n50\n40\n30\n50 100 150 200 250 300 350 400 450 500 550 600\nTime (sec)\n2OCV/EV\n&\n2OV/EV\nCHO (kcal/min)\nFAT (kcal/min)\n0.0\n0 50 100 150 200 250 300 350 400 450 500 550 600\nTime [sec]\n)nim/lack(TAF\n/\n)nim/lack(OHC\n3.0\n2.5 Total Cal (kcal/min)\nFAT (kcal/min)\n2.0\n1.5\n1.0\n0.5\n0.0\n50 100 150 200 250 300 350 400 450 500 550 600\nTime [sec]\n)nim/lack(\ntaF/laC\nlatoT\nWatts\nSpeed\n0 0.0\n0 50 100 150 200 250 300 350 400 450 500 550 600\nTime [sec]\nWatts Speed\nFAT (kcal/min)\nCHO (kcal/min)\nWatts\nHR [bpm]\n80\n0.0 0\n50 100 150 200 250 300 350 400 450 500 550 600\nTime [sec]\n)nim/lack(\nTAF/OHC\nWatts\nHR\n(bpm)",
    "5.0\n4.0\n3.0\n2.0\n1.0\n0.0\n0.0 1.0 2.0 3.0 4.0 5.0\nVO2 (L/min)\n)nim/L(\n2OCV\n200\n150\n100\n50\n0\n0.0 1.0 2.0 3.0 4.0 5.0\nVO2 (L/min)\n)nim/L(\nEV\n200\n150\n100\n50\n0\n0.0 1.0 2.0 3.0 4.0 5.0\nVCO2 (L/min)\n)nim/L(\nEV\n50\nVE/VO2\n40\nVE/VCO2\n30\n20\n10\n0\n0.0 1.0 2.0 3.0 4.0 5.0\nVO2 (L/min)\n)-(\n2OV\n/\nEV\n5.0\n4.0\n3.0\n2.0\n1.0\n0.0\n0 50 100 150 200 250 300 350 400\nWL (Watts)\n)nim/L(\n2OV\n5.0\n4.0\n3.0\n2.0\n1.0\n0.0\n0 50 100 150 200 250 300 350 400\nWL (Watts)\n)nim/L(\n2OCV\n2.0\n1.5\n1.0\n0.5\n0.0\n0.0 1.0 2.0 3.0 4.0 5.0\nVO2 (L/min)\n)-(\nRER\n200\n150\n100\n50\n0\n0.0 1.0 2.0 3.0 4.0 5.0\nVO2 (L/min)\n)mpb(\nRH"
  ],
  "peptide_recommendations": [
    {
      "name": "MOTS-c",
      "dosage": "4mg",
      "frequency": "3x per week",
      "duration": "Continuous",
      "priority": 1,
      "category": "Metabolic Optimization",
      "rationale": "Biological age 4 years younger - MOTS-c maintains mitochondrial health and metabolic advantage.",
      "mechanism": "Mitochondrial function, insulin sensitivity, metabolic regulation"
    },
    {
      "name": "AOD-9604",
      "dosage": "278mcg",
      "frequency": "Daily on empty stomach",
      "duration": "12-16 weeks",
      "priority": 1,
      "category": "Fat Loss",
      "rationale": "Fat burning efficiency is LOW at 51% - AOD-9604 specifically targets lipolysis without affecting insulin.",
      "mechanism": "Mimics GH fat-burning region, lipolytic activity, anti-lipogenic"
    }
  ]
}